Literature DB >> 11500383

The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially.

C Rada1, C Milstein.   

Abstract

Somatic hypermutation, essential for the affinity maturation of antibodies, is restricted to a small segment of DNA. The upstream boundary is sharp and is probably related to transcription initiation. However, for reasons unknown, the hypermutation domain does not encompass the whole transcription unit, notably the C-region exon. Since analysis of the downstream decay of hypermutation is obscured by sequence-dependent hot and cold spots, we describe a strategy to minimize these fluctuations by computing mutations of different sequences located at similar distances from the promoter. We pool large databases of mutated heavy and light chains and analyse the decay of mutation frequencies. We define an intrinsic decay of probability of mutation that is remarkably similar for heavy and light chains, faster than anticipated and consistent with an exponential fit. Indeed, quite apart from hot spots, the intrinsic probability of mutation at CDR1 can be almost twice that of CDR3. The analysis has mechanistic implications for current and future models of hypermutation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500383      PMCID: PMC125579          DOI: 10.1093/emboj/20.16.4570

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation.

Authors:  L Bross; Y Fukita; F McBlane; C Démollière; K Rajewsky; H Jacobs
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

Review 2.  Transcription, beta-like DNA polymerases and hypermutation.

Authors:  C A Reynaud; S Frey; S Aoufouchi; A Faili; B Bertocci; A Dahan; E Flatter; F Delbos; S Storck; C Zober; J C Weill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

3.  Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes.

Authors:  F N Papavasiliou; D G Schatz
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

Review 4.  RNA polymerase II elongation through chromatin.

Authors:  G Orphanides; D Reinberg
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

5.  Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene.

Authors:  S G Lebecque; P J Gearhart
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

6.  Distribution of mutations around rearranged heavy-chain antibody variable-region genes.

Authors:  G W Both; L Taylor; J W Pollard; E J Steele
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

7.  Position of the rearranged V kappa and its 5' flanking sequences determines the location of somatic mutations in the J kappa locus.

Authors:  J S Weber; J Berry; T Manser; J L Claflin
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

Review 8.  The role of promoter-intron interactions in directing hypermutation.

Authors:  D B Winter; N Sattar; P J Gearhart
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

9.  Origin of antibody variation.

Authors:  S Brenner; C Milstein
Journal:  Nature       Date:  1966-07-16       Impact factor: 49.962

10.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more
  42 in total

1.  Error-prone DNA repair activity during somatic hypermutation in shark B lymphocytes.

Authors:  Catherine Zhu; Ellen Hsu
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

2.  Correlation of somatic hypermutation specificity and A-T base pair substitution errors by DNA polymerase eta during copying of a mouse immunoglobulin kappa light chain transgene.

Authors:  Youri I Pavlov; Igor B Rogozin; Alexey P Galkin; Anna Y Aksenova; Fumio Hanaoka; Christina Rada; Thomas A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

3.  Genetic diversity of the allodeterminant alr2 in Hydractinia symbiolongicarpus.

Authors:  Rafael D Rosengarten; Maria A Moreno; Fadi G Lakkis; Leo W Buss; Stephen L Dellaporta
Journal:  Mol Biol Evol       Date:  2010-10-21       Impact factor: 16.240

Review 4.  Does DNA repair occur during somatic hypermutation?

Authors:  Huseyin Saribasak; Patricia J Gearhart
Journal:  Semin Immunol       Date:  2012-06-22       Impact factor: 11.130

5.  Problems in using statistical analysis of replacement and silent mutations in antibody genes for determining antigen-driven affinity selection.

Authors:  Biplab Bose; Subrata Sinha
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

6.  Reconsidering the human immunoglobulin heavy-chain locus: 1. An evaluation of the expressed human IGHD gene repertoire.

Authors:  C E H Lee; B Gaëta; H R Malming; M E Bain; W A Sewell; A M Collins
Journal:  Immunogenetics       Date:  2006-01-10       Impact factor: 2.846

7.  The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination.

Authors:  Eva Besmer; Eleonora Market; F Nina Papavasiliou
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

8.  II. Correlations between secondary structure stability and mutation frequency during somatic hypermutation.

Authors:  Barbara E Wright; Karen H Schmidt; Nick Davis; Aaron T Hunt; Michael F Minnick
Journal:  Mol Immunol       Date:  2008-06-26       Impact factor: 4.407

Review 9.  Regulation of AID, the B-cell genome mutator.

Authors:  Celia Keim; David Kazadi; Gerson Rothschild; Uttiya Basu
Journal:  Genes Dev       Date:  2013-01-01       Impact factor: 11.361

10.  Attracting AID to targets of somatic hypermutation.

Authors:  Atsushi Tanaka; Hong Ming Shen; Sarayu Ratnam; Prashant Kodgire; Ursula Storb
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.